NCT00730821View on ClinicalTrials.gov

Phase I of BIBW 2992/BIBF 1120 Combination Therapy in Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

August 31, 2009

Conditions
Neoplasms
Interventions
DRUG

BIBW 2992

DRUG

BIBF 1120

Trial Locations (4)

Unknown

1239.1.3 Boehringer Ingelheim Investigational Site, Scottsdale

1239.1.1 Boehringer Ingelheim Investigational Site, Tampa

1239.1.2 Boehringer Ingelheim Investigational Site, Detroit

1239.1.4 Boehringer Ingelheim Investigational Site, Omaha

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT00730821 - Phase I of BIBW 2992/BIBF 1120 Combination Therapy in Solid Tumors | Biotech Hunter | Biotech Hunter